Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries

Ostuzzi, Giovanni and Gastaldon, Chiara and Petrini, Carlo and Godman, Brian and Barbui, Corrado (2020) Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries. Epidemiology and Psychiatric Sciences, 29 (6). e126. ISSN 2045-7960

[img]
Preview
 Text (Ostuzzi-etal-EPS-2020-Poor-implementation-of-the-eu-clinical-trial-regulation)
Ostuzzi_etal_EPS_2020_Poor_implementation_of_the_eu_clinical_trial_regulation.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (155kB)| Preview

    Abstract

    The principle of pragmatism in clinical trials has been broadly recognised as a way to close the gap between research and practice. In this contribution, we argue that the conduct of pragmatic clinical trials in Europe may be hampered by poor implementation of current European Union's Clinical Trial Regulation No. 536/2014.

    Creators(s): Ostuzzi, Giovanni, Gastaldon, Chiara, Petrini, Carlo, Godman, Brian and Barbui, Corrado;
    Item type:Article
    ID code:72330
    Keywords:Italian medicine agency, clinical trials, clinical trial regulations, Pharmacy and materia medica, Pharmacology, Toxicology and Pharmaceutics(all)
    Subjects:Medicine > Pharmacy and materia medica
    Department:Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
    Depositing user: Pure Administrator
    Date deposited:07 May 2020 15:49
    Last modified:21 Jan 2021 11:56
    URI:https://strathprints.strath.ac.uk/id/eprint/72330
    Export data:
    CORE (COnnecting REpositories)